Innovations in Care
We provide programs and services that transform the lives of people affected by neuromuscular disease.
Avidity Biosciences - DMD Functional Data - Topline Results
November 11th, 2025
5:00 PM EST
Live, Virtual Webinar
Please join us for this educational webinar as Avidity Biosciences shares the topline functional data from their EXPLORE44 and EXPLORE44-OLE clinical trials. Their investigational treatment, known as del-zota, is in development for boys and men with Duchenne muscular dystrophy amenable to exon-44 skipping.
